ABEO

2.4201.22%
SG

Steven Gray

Member of Scientific Advisory Board

Dr. Steven Gray, Ph.D., was Member of Scientific Advisory Board of Form Bio, Inc. Dr. Gray has been a Member of Scientific Advisory Board at Sarepta Therapeutics, Inc. since December 2019. Dr. Gray has been a Member of Scientific Advisory Board at Abeona Therapeutics Inc. Since April 7, 2017. He is Chief Scientific Advisor of UT Southwestern Gene Therapy Program at Taysha Gene Therapies, Inc. He serves as Scientific & Clinical Advisor at Nanoscope Therapeutics Inc. He is an Associate Professor in the Department of Pediatrics at the University of Texas Southwestern (UTSW). He performed a postdoctoral fellowship focusing on gene therapy in the laboratory of Jude Samulski at UNC-Chapel Hill. Dr. Gray is the director of the UTSW Viral Vector Facility and maintains affiliations with the Department of Molecular Biology, the Department of Neurology and Neurotherapeutics, the Eugene McDermott Center for Human Growth and Development and the Hamon Center for Regenerative Science and Medicine at UTSW. Dr. Gray's core expertise is in AAV gene therapy vector engineering, followed by optimizing approaches to deliver a gene to the nervous system. As AAV-based platform gene transfer technologies have been developed to achieve global, efficient and in some cases cell-type specific CNS gene delivery, his research focus has also included preclinical studies to apply these reagents toward the development of treatments for neurological diseases. Dr. Gray earned his PhD in molecular biology from Vanderbilt University in 2006, after earning a BS from Auburn University. Dr. Gray is Member of Scientific Advisors at Lysogene S.A.

Positions